You are currently viewing a new version of our website. To view the old version click .
by
  • Qiuping Li1,2,3,* and
  • You Zhou4,*

Reviewer 1: Rasim Alosmanov Reviewer 2: Wissam Farhat

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

 

Minor point:

What is mean FDA and EFSA (page 1, Line 42-43).

 

Major point:

It is well-known that one of the biological applications of the mesoporous silica molecular sieve are preparation as hemostatic materials. The authors should be considering this fact. And to include the corresponding section information about the application mesoporous silica molecular sieve in this field.

In this narrative review, the brief discovery history of mesoporous silica and some important mesoporous silica families are summarized


I searched and have not found such kind of published review paper in this field

The authors should taking into account the following published papers
- http://yxsj.smmu.edu.cn/en/article/id/20120405
- https://sciendo.com/de/article/10.2478/s13536-013-0116-6
- https://pubs.acs.org/doi/10.1021/tx300166u

Author Response

Please see the attachment.

Author Response File: Author Response.doc

Reviewer 2 Report

This manuscript provides a literature review of the preparation methods and biological applications of mesoporous silica molecular sieves. There is significant interest in mesoporous silica in the biomedical field, but this paper does not address the topic in a meaningful manner and most of the details reviewed are available in many similar papers. Furthermore, the manuscript's syntax and grammar render it unintelligible. For the mentioned reasons, I suggest rejection.

Author Response

Please see the attachment.

Author Response File: Author Response.doc

Round 2

Reviewer 1 Report

Can be accepted

Reviewer 2 Report

I think that the paper is improved and can be accepted for publication